David is a Senior Counsel in the Innovation department. He advises clients on the acquisition, commercialisation, and enforcement of intellectual property rights in the life sciences, software, and general commercial sectors.
David's has a particular interest in acting for clients working in the fields of cell therapies, synthetic biology, and free and open source software.